7125-73-7 Usage
Uses
Used in Pharmaceutical Industry:
Flumetramide is used as a skeletal muscle relaxant for the treatment of muscle spasms and related conditions. Its mechanism of action involves targeting specific receptors in the muscle tissue, leading to a reduction in muscle tension and pain relief.
Used in Chemical Synthesis:
Flumetramide serves as a reagent in the preparation of various morpholine-based pharmaceuticals. Its unique chemical structure allows for the creation of a wide range of compounds with potential therapeutic applications.
Used in Ortho-McNeil's Duraflex:
Flumetramide is also utilized under the brand name Duraflex by Ortho-McNeil, where it is specifically formulated to address muscle-related issues and provide targeted relief. Its inclusion in this product highlights its effectiveness and versatility in the pharmaceutical market.
Check Digit Verification of cas no
The CAS Registry Mumber 7125-73-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,1,2 and 5 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 7125-73:
(6*7)+(5*1)+(4*2)+(3*5)+(2*7)+(1*3)=87
87 % 10 = 7
So 7125-73-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H10F3NO2/c12-11(13,14)8-3-1-7(2-4-8)9-5-15-10(16)6-17-9/h1-4,9H,5-6H2,(H,15,16)
7125-73-7Relevant academic research and scientific papers
RORγ ANTAGONIST AND APPLICATION THEREOF IN MEDICINE
-
, (2020/02/06)
Provided herein are compounds as RORγ antagonist having Formula (I). The compounds or pharmaceutical composition thereof can be used for regulating Retinoid-related orphan receptor gamma t (RORγt). Also provided herein are methods of preparation of the compounds and composition thereof, and uses thereof in treating or preventing RORγt mediated inflammation or autoimmune diseases in mammals, particularly humans.
DOPAMINE D3 RECEPTOR ANTAGONISTS HAVING A MORPHOLINE MOIETY
-
, (2018/11/21)
The disclosure provides compounds of formula (I) or pharmaceutically acceptable salts thereof: The disclosure also provides processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them, and their use
Novel morpholine scaffolds as selective dopamine (DA) D3 receptor antagonists
Micheli, Fabrizio,Cremonesi, Susanna,Semeraro, Teresa,Tarsi, Luca,Tomelleri, Silvia,Cavanni, Paolo,Oliosi, Beatrice,Perdon, Elisabetta,Sava, Anna,Zonzini, Laura,Feriani, Aldo,Braggio, Simone,Heidbreder, Christian
, p. 1329 - 1332 (2016/02/23)
A new series of morpholine derivatives has been identified as selective DA D3 receptor antagonists; their in vitro profile and pharmacokinetic data are provided.
